XTSE
KITS
Market cap417mUSD
, Last price
CAD
Name
Kits Eyecare Ltd
Chart & performance
P/E
—
P/S
—
EPS
0.09
Vol. 1Y
—
Shs. 5Y
1.83%
Rev. 5Y
21.88%
Div Yld LY
—
Div Yld TTM
—
Revenues
202m
+26.96%
Net income
3m
-0.27%
CFO
11m
-12.14%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Kits Eyecare Ltd. delivers an online platform dedicated to eye care services and products, catering to consumers throughout the United States and Canada. The company produces its own progressive and contact lenses, as well as eyeglasses and frames under the proprietary KITS brand. Additionally, it distributes a diverse selection of eyewear from various other manufacturers. Its commercial activities are channeled through a network of optical e-commerce sites, notably KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. Established in 2018, the firm maintains its principal office in Vancouver, Canada.
Key people
Choo Zhe
Chief Financial Officer · since 2024
Joseph Thompson
Chief Operating Officer · since 2018
Angela MacInnis
Chief Marketing Officer · since 2026
Tai Silvey
Chief Business Development Officer · since 2023
Nicholas Bozikis
Lead Independent Director · since 2024
Arshil Abdulla
Chief Technology Officer, Director · since 2024
Roger Hardy
Chairman of the Board, Chief Executive Officer · since 2018
Anne Kavanagh
Independent Director · since 2020
Peter Lee
Independent Director · since 2020
Andrew Reid
Independent Director · since 2024
Headquarters & legal address
510 Seymour Street
Suite 1020
Vancouver, BC V6B 3J5
CA
Suite 1020
Vancouver, BC V6B 3J5
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||